Möchten Sie immer auf dem neuesten Stand bleiben?

Company announcement – No. 17 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, May 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...

Press release – No. 12 / 2019 Zealand Pharma to attend Jefferies and Goldman Sachs Global Healthcare Conferences Copenhagen, May 27, 2019 – Zealand Pharma Chief Executive Officer Emmanuel...

Press Release – No. 09 / 2019   Zealand Pharma hosts conference call on May 16 at 4 pm CET (10 am EST) to present first quarter results for 2019 Copenhagen, May 6, 2019 – Zealand Pharma A/S...

Company announcement – No. 14 / 2019 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants                           Copenhagen, April 17, 2019...

Press release – No. 08 / 2019 Zealand Pharma to attend ABG Sundal Collier Small & Mid Cap Seminar Copenhagen, April 11, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend the...

Company announcement – No. 13 / 2019 Zealand Pharma grants new warrants under employee warrant program Copenhagen, April 10, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50...

Press release – No. 07 / 2019 Zealand Pharma to attend Kempen Life Sciences Conference Copenhagen, April 08, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend the Kempen Life...

Company announcement – No. 12 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, April 5, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...

Company announcement – No. 11 / 2019 Zealand Pharma announces Emmanuel Dulac as new CEO Emmanuel Dulac will join Zealand Pharma as new Chief Executive Officer on April 22, 2019. Emmanuel comes from...

Company announcement – No. 10 / 2019 Zealand Pharma’s Annual General Meeting in 2019 Copenhagen, April 4, 2019 - Today, Zealand Pharma A/S (Zealand) (CVR-no. 20 04 50 78) held its Annual General...